ireland Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in pharmacology. I have worked for Servier for my entire career. I started in the industry as a medical representative for the company. I went…
Servier Czech Republic You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets? The first difference is of course the size of the market—the Czech Republic has a market value of approximately 2Bn…
Servier China In 2012 Servier China became the 3rd largest affiliate within the Servier group. How has the company progressed since then? Servier-China is a linchpin for Servier. Servier-China has become the biggest subsidiary in terms of personnel, with over 1200 people, and today we are number one in the Company in…
Servier Poland Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in Romania, Russia, and Bulgaria, but also Vietnam, what is unique here? What is there in Poland that is attracting the…
Servier China Servier was one of the first pharmaceutical companies to establish a presence in China back in 1979. How has Servier’s presence evolved alongside China’s huge transformations of the last decades? Indeed, we are very proud to be one of the pioneering foreign companies in China’s pharmaceutical market. The year was…
Servier Brasil When we met Servier Brazil five years ago the company had major ambitions: ‘grow more than 10% for the five following years’. How have these expectations turned out to be? Actually, these projections turned out to be quite conservative. In the last two years Servier has doubled its Brazilian revenues…
SERVIER Laboratories (Australia) Pty Ltd Servier was eligible to receive $7 million in P3 funding; can you tell us how this initiative has helped the company? P3 was not one of the main reasons why Servier has invested more in Australia of late. What drives Servier’s headquarters to conduct more research in Australia is a…
Servier Russia With the announcement of the Pharma 2020 strategy to develop the domestic pharmaceutical industry, multinational companies have pledged an excess of $1Bn in investment into local infrastructure. Servier, however, preempted this drive, and has had a Russian facility since 2007, the same year you took this position. Russia has traditionally…
Servier South Korea You have recently been appointed as General Manager of Servier in South Korea, after coming from several years working in Europe. What perception did you have of the far-way Korean pharmaceutical sector before your arrival? I did not have much knowledge of the Korean pharmaceutical industry prior to my arrival,…
Servier Indonesia How challenging is it being for you to adapt to the Indonesian business mindset. My adaptation to Indonesia has been relatively smooth thanks to my past experience in different Asian countries including Indonesia itself. More than ten years ago, I had the opportunity to come to Indonesia, where I started…
See our Cookie Privacy Policy Here
